ArticleBMC nephrology2025
Efficacy and safety of PCSK9 inhibitors in patients with chronic kidney disease.
Haixia Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleBMC nephrology2025
Haixia Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.